[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356001-105":59,"doc-detail-356001-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","fak-and-pyk2-paralogous-kinases-with-opposing-roles-in-vasculogenic-mimicry-in-triple-negative-breast-cancer","FAK and Pyk2: Paralogous Kinases with Opposing Roles in Vasculogenic Mimicry in Triple-Negative Breast Cancer","","Vasculogenic mimicry (VM) enables aggressive cancer cells to form vessel-like networks that support microcirculation, metastasis, and resistance to anti-angiogenic therapies. VM is prominent in triple-negative breast cancer (TNBC), yet its molecular regulators remain incompletely defined. This study examines focal adhesion kinase (FAK) and Pyk2 using transcriptomic clinical-expression profiling and patient datasets, then validates effects with TNBC cell functional assays and tube-formation. Results indicate FAK promotes VM whereas Pyk2 suppresses VM at elevated levels, with opposite associations in TCGA-BRCA and METABRIC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fak-and-pyk2-paralogous-kinases-with-opposing-roles-in-vasculogenic-mimicry-in-triple-negative-breast-cancer/356001/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fak-and-pyk2-paralogous-kinases-with-opposing-roles-in-vasculogenic-mimicry-in-triple-negative-breast-cancer/356001.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is vasculogenic mimicry (VM) and why is it important in TNBC?","Question",{"text":112,"@type":113},"VM is a non-endothelial tumor vascularization program where aggressive cancer cells assemble into perfusable, vessel-like structures. In TNBC it supports microcirculation, metastasis, and resistance to anti-angiogenic therapies, and it is linked to worse outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do FAK and Pyk2 contribute differently to VM in TNBC cells?",{"text":117,"@type":113},"Knockdown of FAK, but not Pyk2, impairs robust 3D vessel-like network formation in Matrigel. Conversely, overexpression of Pyk2, but not FAK, reduces vessel-like network formation, indicating opposing roles.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the patient-cohort analyses (TCGA-BRCA and METABRIC) show about FAK and Pyk2 in TNBC?",{"text":121,"@type":113},"The analyses show selective upregulation of FAK in TNBC. In contrast, Pyk2 is inversely associated with VM-associated gene expression in patient tumors, supporting antagonistic functions of the two kinases.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356001,1790179502,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Article  \nFAK and Pyk2: Paralogous Kinases with Opposing Roles in Vasculogenic Mimicry in Triple-Negative Breast Cancer  \nShilpa Madhavan-Kadali 1, Tal Sneh 1, Naamah Bloch 1, Joseph D. Rosenblatt 2, Abraham O. Samson 1, * and Hava Gil-Henn 1,3, *  \nAcademic Editor: Alessandro Canella  \nReceived: 8 June 2026  \nRevised: 27 June 2026  \nAccepted: 2 July 2026  \nPublished: 6 July 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel; [sashacasper5@gmail.com](sashacasper5@gmail.com) (S.M.-K.)  \n2 Department of Medicine, Division of Hematology, Sylvester Comprehensive Cancer Centre, University of Miami Miller School of Medicine, Miami, FL 33136, USA  \n3 Integrated Imaging Program for Cancer Research, Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA  \n* Correspondence: [samsona@biu.ac.il](samsona@biu.ac.il) (A.O.S.); [hava.gilhenn@einsteinmed.edu](hava.gilhenn@einsteinmed.edu) (H.G.-H.)  \nAbstract  \nVasculogenic mimicry (VM) is a non-endothelial mode of tumor vascularization in which aggressive cancer cells form vessel-like networks that support microcirculation, metastasis, and resistance to anti-angiogenic therapies. VM is particularly prominent in triple-negative breast cancer (TNBC), but its molecular regulators remain incompletely understood. Focal adhesion kinase (FAK) and its paralog, proline-rich tyrosine kinase 2 (Pyk2), are closely related non-receptor tyrosine kinases implicated in epithelial-to-mesenchymal transition (EMT), invasion, and metastasis in TNBC. However, their roles in VM have not been defined. Here we perform transcriptomic analysis of FAK and Pyk2 clinical expression patterns using TNMplot V2, DepMap, and patient cohort datasets to systematically dissect the distinct contributions of FAK and Pyk2 to VM in TNBC. Our in vitro tube formation assay shows that in TNBC cells, knockdown of FAK, but not Pyk2, results in failure to form robust 3D vessel-like networks in Matrigel. Similarly, overexpression of Pyk2, but not FAK, in TNBC cells results in poor vessel-like network formation. Consistent with these findings, analysis of two independent patient cohorts (TCGA-BRCA and METABRIC) revealed selective upregulation of FAK in TNBC, while Pyk2 was inversely associated with vasculogenic-mimicry-associated gene expression, supporting the opposing roles of the two kinases in patient tumors. Taken together, these findings establish that FAK and Pyk2 govern VM through non-redundant, kinase-specific, and functionally opposed mechanisms: FAK acting as a positive regulator of VM, and Pyk2 as a context dependent suppressor of VM at elevated levels. These results nominate FAK as a candidate target for suppressing VM-driven tumor perfusion in TNBC and suggest that dual FAK/Pyk2 inhibition warrants caution hypotheses that remain to be tested pharmacologically.  \nKeywords: vasculogenic mimicry; triple negative breast cancer; Pyk2; PTK2B; FAK; PTK2; non-receptor tyrosine kinases; focal adhesion kinase; tumor vascularization; cell migration  \n1. Introduction  \nBreast cancer is the most commonly diagnosed cancer in women and a leading cause of cancer-related death worldwide, with an estimated 2.3 million new diagnoses and 670,000 deaths in 2022 [1,2] . If current trends continue, the global burden is projected to rise to approximately 3.2 million new cases and 1.1 million deaths annually by 2050 [2] .  \nTNBC, defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, represents roughly 15–20% of breast carcinomas but accounts for a disproportionate share of breast cancer deaths [3,4] . It tends to arise in younger women and to follow a more aggressive course, with earlier metastasis and hig","cbCailOCevn9gka6","https://ap.wps.com/l/cbCailOCevn9gka6","pdf",26013407,17,"English","# Introduction\n## Vasculogenic mimicry and triple-negative breast cancer\n# Abstract\n## Study rationale and approach\n## Experimental findings and clinical correlation","[{\"question\":\"What is vasculogenic mimicry (VM) and why is it important in TNBC?\",\"answer\":\"VM is a non-endothelial tumor vascularization program where aggressive cancer cells assemble into perfusable, vessel-like structures. In TNBC it supports microcirculation, metastasis, and resistance to anti-angiogenic therapies, and it is linked to worse outcomes.\"},{\"question\":\"How do FAK and Pyk2 contribute differently to VM in TNBC cells?\",\"answer\":\"Knockdown of FAK, but not Pyk2, impairs robust 3D vessel-like network formation in Matrigel. Conversely, overexpression of Pyk2, but not FAK, reduces vessel-like network formation, indicating opposing roles.\"},{\"question\":\"What do the patient-cohort analyses (TCGA-BRCA and METABRIC) show about FAK and Pyk2 in TNBC?\",\"answer\":\"The analyses show selective upregulation of FAK in TNBC. In contrast, Pyk2 is inversely associated with VM-associated gene expression in patient tumors, supporting antagonistic functions of the two kinases.\"}]","FAK and Pyk2: Paralogous Kinases with Opposing Roles in Vasculogenic Mimicry in Triple-Negative Breast Cancer | PDF",1790122243,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b51da0550f57e9e7326ed9d7286934cf.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0b481d8bf3124bd56bc07094e93d572.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/771e4ae80c45086046e6c5d1e62f07d3.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/583466b688b3dfd3bf8f8ec0f016b679.webp",980,1385]